Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

HUTCHMED (China) Ltd

HCM ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Pharmaceuticals ·

USA Mid Cap Analyst: BUY

Last Close

$12.20

▲ +0.33%

Market Cap $2.13B · Vol 3.38K

Key Metrics

P/E Ratio

118.22

FWD: 28.32

Market Cap

$2.13B

Mid Cap

Div Yield

N/A

EPS Growth

-28.85%

YoY

RSI (14)

67.20

Momentum

Beta

0.26

vs Market

52W High

$18.29

33.30% below

52W Low

$9.90

23.23% above

Volume

3.38K

Avg 11.12K

P/B

1.88

Price-to-book

ROE

N/A

Return on equity

Free Float

99.99%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, HUTCHMED (China) Ltd (HCM) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does HCM pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-2.48%

+8.44%

-3.86%

-17.34%

YTD

-8.48%

-23.13%

-13.17%

-70.35%

Financials & Valuation

TTM · Annual

Total Revenue	$548.51M
Net Income	$457.73M
Revenue Growth (YoY)	+0.22%
Gross Margin	38.68%
Operating Margin	-7.14%
Net Profit Margin	83.45%
ROE	N/A
ROA · ROIC	34.44% · 41.56%

P/E Ratio	118.22
Forward P/E (FY1)	28.32
PEG Ratio	0.00
P/S	4.24
P/B	1.88
P/FCF	N/A
EPS Growth	-28.85%
Outstanding Shares	872.34M

Technical Indicators

50-Day SMA	$11.13
200-Day SMA	$13.41
RSI (14)	67.20
Beta	0.26
52-Week High	$18.29
52-Week Low	$9.90

Volume Today	3.38K
Avg Daily Volume (30D)	11.12K
Relative Volume	0.30x
Volatility (10D)	34.15
Volatility (30D)	41.96
Free Float	99.99%

Analyst Consensus

BUY

Current Price $12.20

Mean Target $19.53

52W Low$9.90 52W High$18.29

Current

Target

$9.90 $18.29

Current Analyst target

+60.04% upside potential · 6 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00B6VCGK9

ISINUS44842L1035

CountryHong Kong

Sub-IndustryPharmaceuticals (NEC)

Earnings DateOct 30, 2026

TypeStocks

Instrument TypeADR American Depositary Receipt

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

HUTCHMED (China) Ltd is an investment holding company principally engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through two segments. Oncology Immunology segment is engaged in the discovery, development and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. Among it, research and development (R&D) includes research and development activities covering drug discovery, development, manufacturing and regulatory functions, out-licensing of in-house developed drugs, as well as administrative activities to support research and development operations, marketed products comprises the invoiced sales, marketing, manufacture and distribution of drugs developed from research and development activities. Other Ventures segment is engaged in the other commercial businesses which include the sales, marketing, manufacture and distribution of other prescription drugs and healthcare products.